Role of the Interventional Radiologist in Pancreatic Whole Organ and Islet Cell Transplantation

2019 ◽  
Vol 03 (04) ◽  
pp. 314-325
Author(s):  
Ketan Y. Shah ◽  
Russell O. Simpson ◽  
Yifan Wang ◽  
Obi T. Okoye ◽  
Mithil B. Pandhi ◽  
...  

AbstractPancreas transplantation is an exciting therapy which has been used for several decades in the treatment of diabetes mellitus. It can be performed as either a whole organ or islet cell transplant. The role of interventional radiologists in the management of whole organ transplants is evolving and includes treatment of postoperative complications and graft biopsy to evaluate for rejection. An in-depth understanding of the transplant anatomy and variations is a fundamental tool in performing these interventions successfully. Islet cell transplantation entails delivery of purified donor pancreatic islet cells into the recipient portal vein. Because of their expertise in image-guided access to the portal system, interventional radiologists play a crucial role in this procedure. The purpose of this article is to review the indications, anatomy, complications, and outcomes of both whole organ and islet cell pancreas transplants, followed by a discussion of the role of interventional radiologists in each procedure.

2001 ◽  
Vol 1 (1) ◽  
pp. 109-119 ◽  
Author(s):  
William F Kendall ◽  
Bradley H Collins ◽  
Emmanuel C Opara

Author(s):  
Siddharth Narayanan ◽  
Gopalakrishnan Loganathan ◽  
Maheswaran Dhanasekaran ◽  
Michael J Hughes ◽  
Stuart K Williams ◽  
...  

Antioxidants ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. 321 ◽  
Author(s):  
Alberto Jarrin Lopez ◽  
Hien Lau ◽  
Shiri Li ◽  
Hirohito Ichii

Permanent pancreatic islet cell destruction occurs in type 1 diabetes mellitus (T1DM) through the infiltration of inflammatory cells and cytokines. Loss of β-cell integrity secondary to oxidation leads to an inability to appropriately synthesize and secrete insulin. Allogenic islet cell transplantation (ICT) has risen as a therapeutic option to mitigate problematic hypoglycemia. Nevertheless, during the process of transplantation, islet cells are exposed to oxidatively caustic conditions that severely decrease the islet cell yield. Islet cells are at a baseline disadvantage to sustain themselves during times of metabolic stress as they lack a robust anti-oxidant defense system, glycogen stores, and vascularity. The Nrf2/Keap1 system is a master regulator of antioxidant genes that has garnered attention as pharmacologic activators have shown a protective response and a low side effect profile. Herein, we present the most recently studied Nrf2/Keap1 activators in pancreas for application in ICT: Dh404, dimethyl fumarate (DMF), and epigallocatechin gallate (EGCG). Furthermore, we discuss that Nrf2/Keap1 is a potential target to ameliorate oxidative stress at every step of the Edmonton Protocol.


2012 ◽  
Vol 67 (9) ◽  
pp. 923-931 ◽  
Author(s):  
S. Dixon ◽  
C.R. Tapping ◽  
J.N. Walker ◽  
M. Bratby ◽  
S. Anthony ◽  
...  

2021 ◽  
Vol 105 (12S1) ◽  
pp. S42-S42
Author(s):  
Saloni Aggarwal ◽  
Sandra Kelly ◽  
Joy Paramor ◽  
Karen Seeberger ◽  
Mandy Rosko ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document